Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

Mouse models treated with the sleep aid lemborexant had less brain damage compared to controls and mice that received a ...

The IDMO Smart Factory initiative has the potential to help advance the development and approval of CAR-T therapeutics in ...

Fetal bovine serum (FBS) has long served as a foundational input for cell culture, tissue engineering, and biomanufacturing.

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

The latest imaging method from the Broad Institute uncovers structural disruptions in the nucleus associated with progeria at ...

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

A scientist says he has shown that it’s possible to produce a large amount of virus-like particles using a fully scalable ...

BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of ...